A 1 SER 0 -12.871 -11.391
A 2 ASP 2 -10.450 -9.478
A 3 LYS 16 -14.335 -14.527
A 4 ILE 15 -16.120 -15.991
A 5 ILE 19 -16.104 -16.437
A 6 HIS 9 -13.383 -12.879
A 7 LEU 29 -12.707 -14.581
A 8 THR 2 -7.483 -6.852
A 9 ASP 10 -6.950 -7.301
A 10 ASP 0 -4.730 -4.186
A 11 SER 12 -7.312 -7.851
A 12 PHE 26 -11.382 -13.063
A 13 ASP 3 -9.490 -8.744
A 14 THR 7 -9.763 -9.445
A 15 ASP 20 -12.376 -13.253
A 16 VAL 31 -16.537 -18.200
A 17 LEU 10 -14.791 -14.240
A 18 LYS 4 -12.217 -11.272
A 19 ALA 24 -14.688 -15.759
A 20 ASP 2 -14.631 -13.178
A 21 GLY 7 -16.390 -15.310
A 22 ALA 20 -19.975 -19.978
A 23 ILE 23 -21.965 -22.084
A 24 LEU 29 -23.358 -24.007
A 25 VAL 38 -21.841 -23.700
A 26 ASP 29 -20.983 -21.905
A 27 PHE 31 -17.833 -19.347
A 28 TRP 22 -15.876 -16.580
A 29 ALA 25 -11.420 -12.982
A 30 GLU 5 -9.345 -8.845
A 31 TRP 14 -8.003 -8.692
A 32 CYS 14 -12.080 -12.301
A 33 GLY 10 -11.472 -11.302
A 34 PRO 19 -6.901 -8.292
A 35 ILE 7 -6.039 -6.149
A 36 GLU 23 -3.879 -6.078
A 37 GLU 2 0.409 0.132 <=B
A 38 SER 2 0.948 0.609 <=B
A 39 ASP 7 0.684 -0.200 <=B
A 40 ASP 2 0.916 0.580 <=B
A 41 ARG 6 -0.453 -1.091 <=B
A 42 ARG 19 -2.045 -3.995
A 43 TYR 13 -3.778 -4.839
A 44 ASP 6 -4.162 -4.374
A 45 LEU 3 -5.161 -4.913
A 46 VAL 21 -6.423 -8.099
A 47 GLY 1 -8.352 -7.507
A 48 PRO 16 -11.127 -11.687
A 49 CYS 12 -13.508 -13.335
A 50 LYS 29 -17.036 -18.411
A 51 MET 8 -16.719 -15.716
A 52 ILE 19 -18.936 -18.943
A 53 ALA 28 -20.809 -21.636
A 54 PRO 7 -16.233 -15.172
A 55 ILE 10 -15.614 -14.969
A 56 LEU 25 -18.598 -19.334
A 57 ASP 19 -19.003 -19.003
A 58 GLU 8 -13.233 -12.631
A 59 ILE 13 -13.339 -13.300
A 67 LEU 25 -19.068 -19.750
A 68 THR 21 -21.074 -21.065
A 69 VAL 26 -21.441 -21.966
A 70 ALA 31 -20.074 -21.331
A 71 LYS 20 -18.114 -18.331
A 72 LEU 34 -15.060 -17.238
A 73 ASN 8 -11.932 -11.480
A 74 ILE 27 -8.440 -10.574
A 75 ASP 12 -4.489 -5.353
A 76 GLN 12 -4.527 -5.387
A 77 ASN 23 -5.140 -7.193
A 78 PRO 5 -3.746 -3.890
A 79 GLY 9 -4.138 -4.697
A 80 THR 32 -8.639 -11.326
A 81 ALA 24 -10.684 -12.215
A 82 PRO 11 -5.079 -5.759
A 83 LYS 19 -6.878 -8.272
A 84 TYR 32 -11.189 -13.583
A 85 GLY 4 -8.397 -7.892
A 86 ILE 32 -11.616 -13.960
A 87 ARG 1 -8.815 -7.917
A 88 GLY 12 -10.758 -10.901
A 89 ILE 30 -14.314 -16.118
A 90 PRO 29 -16.891 -18.284
A 91 THR 19 -18.830 -18.849
A 92 LEU 27 -22.137 -22.696
A 93 LEU 25 -21.666 -22.049
A 94 LEU 20 -22.859 -22.530
A 95 PHE 23 -20.526 -20.811
A 96 LYS 11 -18.751 -17.860
A 97 ASN 3 -15.541 -14.098
A 98 GLY 9 -14.926 -14.245
A 99 GLU 3 -15.376 -13.952
A 100 VAL 14 -18.514 -17.995
A 101 ALA 18 -19.082 -18.958
A 102 ALA 12 -20.931 -19.904
A 103 THR 15 -20.186 -19.590
A 104 LYS 25 -19.611 -20.230
A 105 VAL 10 -17.762 -16.870
A 106 GLY 0 -14.663 -12.977
A 107 ALA 21 -17.225 -17.659
A 108 LEU 16 -18.013 -17.782
A 109 SER 1 -15.867 -14.157
A 110 LYS 9 -15.986 -15.183
A 111 GLY 0 -13.616 -12.050
A 112 GLN 10 -16.765 -15.987
A 113 LEU 27 -20.650 -21.380
A 114 LYS 7 -17.665 -16.438
A 115 GLU 8 -15.641 -14.762
A 116 PHE 27 -20.511 -21.257
A 117 LEU 25 -21.553 -21.950
A 118 ASP 8 -16.971 -15.939
A 119 ALA 9 -16.042 -15.232
A 120 ASN 23 -18.003 -18.577
A 121 LEU 19 -17.429 -17.610
A 122 ALA 3 -14.205 -12.917

Identified 5 B-Cell epitope residues out of 115 total residues